One protein mitigates Huntington’s disease while another one exacerbates it by regulating the huntingtin protein’s movement in neurons.

Chromatography has long been a bioprocess cornerstone but many platforms today are struggling to keep up with scale, speed, ...

Weeks after an injection of stem cells delivered to the brain, 80% of patients had improved CSF biomarkers with no adverse effects.

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

Immunai, an AI biotech company specializing in mapping the human immune system, and the Parker Institute for Cancer Immunotherapy (PICI), a San Francisco-based nonprofit organization that unites ...

Zevaskyn won FDA approval upon Abeona’s second filing of a biologics license application (BLA) for the therapy.

Scientists identified broadly neutralizing antitoxin antibodies in blood from snake venom-exposed hyperimmune donor for ...

Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug ...

Researchers say that while a new study has implications for neurodegenerative disease research, its more immediate impact ...